These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 25747115)

  • 21. Autoimmune hepatitis and overlap syndromes.
    Dienes HP; Erberich H; Dries V; Schirmacher P; Lohse A
    Clin Liver Dis; 2002 May; 6(2):349-62, vi. PubMed ID: 12122860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Autoimmune cholangitis or primary biliary cirrhosis without antimitochondrial antibodies?].
    Saló J; Caballería L; Bruguera M; Parés A; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):5-10. PubMed ID: 9072202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis.
    Buckley SE; DiPalma JA
    Am Fam Physician; 1996 Jan; 53(1):195-200. PubMed ID: 8546046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overlap of IgG4-related sclerosing cholangitis and primary biliary cirrhosis.
    Takemoto R; Miyake Y; Harada K; Nakanuma Y; Moriya A; Ando M; Hirohata M; Yamamoto K
    Intern Med; 2014; 53(13):1429-33. PubMed ID: 24990335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and therapeutic questions in overlap syndromes of autoimmune hepatitis.
    Premoli A; Morello E; Bo S; Durazzo M
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):79-82. PubMed ID: 17415345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporary resolution of obstructive jaundice during ursodeoxycholic acid therapy in a patient with primary sclerosing cholangitis and a dominant biliary stricture.
    Fracchia M; Soubrane O; Houssin D; Galatola G
    Ital J Gastroenterol; 1995; 27(8):430-5. PubMed ID: 8775469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of IgG4-related sclerosing cholangitis overlapped with primary biliary cirrhosis.
    Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Shimizu S; Kondo H; Yoshida M; Yamashita H; Nojiri S; Takahashi S; Joh T
    Intern Med; 2012; 51(13):1695-9. PubMed ID: 22790128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol.
    Ghonem NS; Auclair AM; Hemme CL; Gallucci GM; de la Rosa Rodriguez R; Boyer JL; Assis DN
    Clin Pharmacol Ther; 2020 Dec; 108(6):1213-1223. PubMed ID: 32480421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathologic diagnosis of autoimmune liver disease].
    Pan MH; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):772-6. PubMed ID: 18307886
    [No Abstract]   [Full Text] [Related]  

  • 30. Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?
    Gisbert JP; Jones EA; Pajares JM; Moreno-Otero R
    Aliment Pharmacol Ther; 2003 Jan; 17(1):17-27. PubMed ID: 12492729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Biliary Cholangitis and Autoimmune Hepatitis.
    Gonzalez RS; Washington K
    Surg Pathol Clin; 2018 Jun; 11(2):329-349. PubMed ID: 29751878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
    Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
    J Autoimmun; 2018 Dec; 95():144-158. PubMed ID: 30366656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Primary biliary cirrhosis. Primary sclerosing cholangitis].
    Corpechot C; Chazouilleres O
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):325-32. PubMed ID: 12769103
    [No Abstract]   [Full Text] [Related]  

  • 35. Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis.
    Cho YJ; Han DS; Kim TY; Jang SJ; Jeon YC; Sohn JH; Lee IH; Park KN
    J Korean Med Sci; 1999 Feb; 14(1):102-6. PubMed ID: 10102534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overlap syndromes of autoimmune hepatitis: an open question.
    Durazzo M; Premoli A; Paschetta E; Belci P; Spandre M; Bo S
    Dig Dis Sci; 2013 Feb; 58(2):344-8. PubMed ID: 23086110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary biliary cirrhosis and primary sclerosing cholangitis.
    Angulo P; Lindor KD
    Clin Liver Dis; 1999 Aug; 3(3):529-70. PubMed ID: 11291238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of cholestatic liver disease].
    Pleşa A
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical management of autoimmune biliary diseases.
    Imam MH; Talwalkar JA; Lindor KD
    J Autoimmun; 2013 Oct; 46():88-96. PubMed ID: 23860242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.